Sugi Predict

Sugi Predict / Compounds / SCHEMBL2408910

SCHEMBL2408910

SCHEMBL2408910

Nc1cc(F)cc(-c2cccc(C(=O)O)c2)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMO O15229 1/20 0.47
▸ ERN1 O75460 2/20 0.47
▸ AKR1C3 P42330 2/20 0.45
▸ AKR1C2 P52895 2/20 0.45
▸ PPIB P23284 1/20 0.43
▸ PPIA P62937 1/20 0.43
▸ PPID Q08752 1/20 0.43
▸ PIN1 Q13526 1/20 0.43
▸ RXRA P19793 1/20 0.43
▸ RXRB P28702 1/20 0.43
▸ DDT P30046 1/20 0.43
▸ CA12 O43570 1/20 0.42
▸ CA1 P00915 1/20 0.42
▸ CA2 P00918 1/20 0.42
▸ CA6 P23280 1/20 0.42
▸ CA9 Q16790 1/20 0.42
▸ MAP2K4 P45985 1/20 0.42
▸ HDAC6 Q9UBN7 2/20 0.42
▸ FOLH1 Q04609 1/20 0.42
▸ HDAC1 Q13547 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL3360448 0.99 KMO (0.46) KMOERN1AKR1C3AKR1C2PPIB
SCHEMBL2407332 0.82 RXRA (0.58) KMOERN1RXRARXRBDDT
SCHEMBL2404438 0.82 KMO (0.47) KMOAKR1C3AKR1C2RXRARXRB
SCHEMBL29629597 0.81 KMO (0.53) KMOERN1RXRARXRBDDT
SCHEMBL407806 0.81 KMO (0.53) KMOERN1RXRARXRBDDT
Hydrochloric Acid SCHEMBL3365401 0.81 KMO (0.46) KMOAKR1C3AKR1C2RXRARXRB
Bromide SCHEMBL1706405 0.80 KMO (0.51) KMOERN1RXRARXRBDDT
Hydrochloric Acid SCHEMBL4861328 0.80 KMO (0.51) KMOERN1RXRARXRBDDT
SCHEMBL3360547 0.78 ERN1 (0.57) KMOERN1PPIAPPIDPIN1
SCHEMBL4346801 0.77 KDM1A (0.53) KMOERN1AKR1C3AKR1C2RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040019190-A1 Thrombopoietin mimetics NOVARTIS AG (CH) 2004-01-29 — — US claimed
EP-1294378-A4 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORP (US) 2004-01-28 — — EP claimed
EP-1294378-A2 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2003-03-26 — — EP claimed
WO-2001089457-A2 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION (US) 2001-11-29 — — WO claimed
US-20150093356-A1 THROMBOPOIETIN MIMETICS GLAXOSMITHKLINE LLC 2015-04-02 — — US disclosed
EP-2236500-B1 BICYCLO-SUBSTITUTED PYRAZOLON AZO DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF JIANGSU HENGRUI MEDICINE CO (CN) 2014-12-24 — — EP disclosed
EP-2236500-B1 BICYCLO-SUBSTITUTED PYRAZOLON AZO DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF JIANGSU HENGRUI MEDICINE CO (CN) 2014-12-24 — — EP disclosed
US-20130123507-A1 BICYCLO-SUBSTITUTED PYRAZOLON AZO DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF SHANGHAI HENGRUI PHARMACEUTICAL CO. LTD. (CN) 2013-05-16 — — US disclosed
US-20130123507-A1 BICYCLO-SUBSTITUTED PYRAZOLON AZO DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF SHANGHAI HENGRUI PHARMACEUTICAL CO. LTD. (CN) 2013-05-16 — — US disclosed
US-20130123507-A1 BICYCLO-SUBSTITUTED PYRAZOLON AZO DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF SHANGHAI HENGRUI PHARMACEUTICAL CO. LTD. (CN) 2013-05-16 — — US disclosed
US-20130078213-A1 THROMBOPOIETIN MIMETICS GLAXOSMITHKLINE LLC 2013-03-28 — — US disclosed
US-8367710-B2 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof JIANGSU HENGRUI MEDICINE CO. LTD. (CN) 2013-02-05 — — US disclosed
US-7335649-B2 Thrombopoietin mimetics SMITHKLINE BEECHAM CORPORATION (US) 2008-02-26 — — US disclosed
EP-1889838-A1 Thrombopoietin mimetics SmithKline Beecham Corporation (US) 2008-02-20 — — EP disclosed
US-7332481-B2 Thrombopoietin mimetics SMITHKLINE BEECHAM CORPORATION (US) 2008-02-19 — — US disclosed
EP-1864981-A1 Thrombopoietin mimetics SmithKline Beecham Corporation (US) 2007-12-12 — — EP disclosed
US-20070179192-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION AND GLAXO GROUP LIMITED 2007-08-02 — — US disclosed
US-20070129338-A1 THROMBOPOIETIN MIMETICS SMITHKLINE BEECHAM CORPORATION 2007-06-07 — — US disclosed
US-7160870-B2 Thrombopoietin mimetics SMITHKLINE BEECHAM CORPORATION (US) 2007-01-09 — — US disclosed
US-20040019190-A1 Thrombopoietin mimetics NOVARTIS AG (CH) 2004-01-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130123507-A1 BICYCLO-SUBSTITUTED PYRAZOLON AZO DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF THPO, MPL, TEK KMO 599/4885ERN1 4746/4885AKR1C3 969/4885
US-20070129338-A1 THROMBOPOIETIN MIMETICS MPL, THPO, TEK KMO 2431/4885ERN1 4239/4885AKR1C3 3361/4885
US-20070179192-A1 THROMBOPOIETIN MIMETICS MPL, THPO, TEK KMO 2431/4885ERN1 4239/4885AKR1C3 3361/4885
US-20150093356-A1 THROMBOPOIETIN MIMETICS MPL, THPO, TEK KMO 2431/4885ERN1 4239/4885AKR1C3 3361/4885
US-20130078213-A1 THROMBOPOIETIN MIMETICS MPL, THPO, TEK KMO 2431/4885ERN1 4239/4885AKR1C3 3361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.